The Latest from our Blog

August 23, 2010

While we like to focus on highly practical solutions that improve maternal survival, we are also interested in solutions still in research and development. Artificial or synthetic blood is one such invention that could change everything. There are several reasons why a woman might need a blood transfusion-chief among them severe anemia or blood loss due to postpartum hemorrhage. Right now, a blood transfusion requires a blood banking system, something that is difficult for many lower-level health facilities. What's more, an enormous number of the transfusions in lower-resource settings are not tested for HIV and Hepatitis. Women are brought in on stretchers, in buses and in cars to facilities where it is often impossible to save them because blood is not available. Story after story is told of husbands and family members rushing around looking for a blood donor. How different could it be if stores of synthetic blood were available?

August 23, 2010

This short clip uses black and white shadowy claymation type figures and yet does a better job than most PSAs we've seen in summing up the effect of maternal mortality on families and on the globe. It was done by Art Center for Design for UNFPA.

August 18, 2010

Our passion is in information design... that saves lives. This graphic depicts our vision for how Maternova will help or organize the field of innovation for maternal/newborn health

August 05, 2010

A huge clinical trial is underway to test TXA acid, a drug used in trauma patients, for use in women with postpartum hemorrhage.

The London School of Hygiene and Tropical Medicine (LSHTM), led by chief investigator Professor Ian Roberts, is currently testing the use of “tranexamic (TXA) acid for the treatment of postpartum hemorrhage.” TXA is a “systemic antifribiololytic agent,” meaning it acts to inhibit clot breakdown (fibriololysys), therefore encouraging clotting and decreasing blood loss in incidents of bleeding. Postpartum hemorrhage is a leading cause of obstetric deaths and positive trial results could provide another tool for saving women's lives.

July 22, 2010

A huge clinical trial is underway to test TXA acid, a drug used in trauma patients, for use in women with postpartum hemorrhage.

Syndicate content